Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib

Overview of attention for article published in BioDrugs, June 2015

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 3,391 followers.

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib https://t.co/SZgT3BtrpB

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib https://t.co/SZgT3BtrpB

More acne stories: Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib. http://t.co/rQV3rfgnKV